Verstovsek Srdan | Department Of Leukemia M.d. Anderson Cancer Center
スポンサーリンク
概要
関連著者
-
KANTARJIAN Hagop
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
VERSTOVSEK Srdan
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
Verstovsek Srdan
Department Of Leukemia M.d. Anderson Cancer Center
-
Kantarjian Hagop
Department Of Leukemia Unit 428 The University Of Texas M. D. Anderson Cancer Center
-
Kantarjian Hagop
Department Of Leukemia The University Of Texas M.d. Anderson Cancer Center
-
Kantarjian Hagop
Department Of Leukemia M.d. Anderson Cancer Center
-
Kantarjian Hagop
Department Of Leukemia The University Of Texas Md Anderson Cancer Center
-
Cortes Jorge
Department Of Leukemia Unit 428 The University Of Texas M. D. Anderson Cancer Center
-
QUINTAS-CARDAMA Alfonso
Department of Leukemia, M.D. Anderson Cancer Center
-
MANSHOURI Taghi
Department of Leukemia, M.D. Anderson Cancer Center
-
Manshouri Taghi
Department Of Leukemia M.d. Anderson Cancer Center
-
Quintas-cardama Alfonso
Department Of Leukemia M.d. Anderson Cancer Center
-
Cortes Jorge
Department Of Leukemia M.d. Anderson Cancer Center
-
SEVER Matjaz
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
ESTROV Zeev
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
NUSSENZVEIG Roberto
Department of Leukemia, M.D. Anderson Cancer Center
-
Prchal Josef
Division Of Hematology School Of Medicine University Of Utah
-
Sever Matjaz
Department Of Leukemia M.d. Anderson Cancer Center
-
Estrov Zeev
Department Of Leukemia The University Of Texas M. D. Anderson Cancer Center
-
Nussenzveig Roberto
Department Of Leukemia M.d. Anderson Cancer Center
-
ORSOLIC Nada
Department of Animal Physiology, Faculty of Science, University of Zagreb
-
BASIC Ivan
Department of Animal Physiology, Faculty of Science, University of Zagreb
-
Pierce Sherry
Department Of Leukemia Unit 428 The University Of Texas M. D. Anderson Cancer Center
-
JAIN Nitin
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
AULT Pat
Department of Leukemia, M.D. Anderson Cancer Center
-
BUESO-RAMOS Carlos
Department of Hematopathology, University of Texas M.D.
-
PRCHAL Josef
Division of Hematology, School of Medicine, University of Utah
-
GAIKWAD Amos
Department of Pediatric-Hematology Oncology, Texas Children's Cancer Center, Baylor College of Medic
-
PRCHAL Josef
Department of Hematology, University of Utah
-
PAN Jingxuan
Department of Leukemia, The University of Texas, Anderson Cancer Center
-
Ault Pat
Department Of Leukemia M.d. Anderson Cancer Center
-
Jain Nitin
Department Of Leukemia The University Of Texas Md Anderson Cancer Center
-
Pan Jingxuan
Department Of Leukemia The University Of Texas Anderson Cancer Center
-
Basic Ivan
Department Of Animal Physiology Faculty Of Science University Of Zagreb
-
Estrov Zeev
Department Of Leukemia Unit 428 The University Of Texas M. D. Anderson Cancer Center
-
Orsolic Nada
Department Of Animal Physiology Faculty Of Science University Of Zagreb
-
Orsolic Nada
Department Of Leukemia The University Of Texas Md Anderson Cancer Center
-
Gaikwad Amos
Department Of Pediatric-hematology Oncology Texas Children's Cancer Center Baylor College Of Me
-
Bueso-ramos Carlos
Department Of Hematopathology University Of Texas M.d.
-
GOLEMOVIC Mirna
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
SCAPPINI Barbara
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
CHANDRA Joya
Department of Pediatrics, The University of Texas MD Anderson Cancer Center
-
GILES Francis
Department of Leukemia, The University of Texas MD Anderson Cancer Center
-
Chandra Joya
Department Of Pediatrics The University Of Texas Md Anderson Cancer Center
-
Giles Francis
Department Of Leukemia The University Of Texas Md Anderson Cancer Center
-
Golemovic Mirna
Department Of Leukemia The University Of Texas Md Anderson Cancer Center
-
Scappini Barbara
Department Of Leukemia The University Of Texas Md Anderson Cancer Center
著作論文
- Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation
- Imatinib mesylate therapy for polycythemia vera : final result of a phase II study initiated in 2001
- The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2^ mutation
- Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406
- Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells